Showing results (221-230 of 276) with videos related to

Sort By:
Pageof 28
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2023
The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian CarcinomasKarolin Heinze, Evan S Cairns, Shelby Thornton, et al.
Geburtshilfe Und Frauenheilkunde|April 8, 2025
Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, June 2024)Markus Wallwiener, Marco Johannes Battista, Eike-Christian Burandt, et al.
Geburtshilfe Und Frauenheilkunde|December 9, 2020
Pelvic Lymphadenectomy in Vulvar Cancer - Does it make sense?Linn Woelber, Mareike Bommert, Katharina Prieske, et al.
Geburtshilfe Und Frauenheilkunde|May 19, 2025
Evaluation of Baseline Characteristics and Therapeutic Management Strategies in Metastatic Cervical Cancer in Germany: A Multicentric Retrospective Longitudinal Observational Study: A Quality Assurance Initiative of the AGO-Study Group and AGO-OK UterusDominik Denschlag, Bastian Czogalla, Florian Heitz, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trialDomenica Lorusso, Marie-Ange Mouret-Reynier, Philipp Harter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 21, 2023
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trialDomenica Lorusso, Marie-Ange Mouret-Reynier, Philipp Harter, et al.
Journal of the National Cancer Institute|April 25, 2026
Health-related quality of life in patients with newly diagnosed advanced ovarian cancer receiving maintenance olaparib plus bevacizumab (PAOLA-1/ENGOT-ov25)Florence Joly, Amélie Anota, Sylvie Chabaud, et al.
European Journal of Cancer (Oxford, England : 1990)|November 13, 2016
Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter studyLinn Woelber, Lis-Femke Griebel, Christine Eulenburg, et al.
The Lancet. Oncology|April 20, 2020
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trialJacobus Pfisterer, Catherine M Shannon, Klaus Baumann, et al.
Cell Reports. Medicine|December 20, 2023
GIInger predicts homologous recombination deficiency and patient response to PARPi treatment from shallow genomic profilesChristian Pozzorini, Gregoire Andre, Tommaso Coletta, et al.
Pageof 28